7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Gelineau Syndrome in 1 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, K | 1 |
| Riehl, J | 1 |
| Mignot, E | 1 |
| Nishino, S | 1 |
1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Gelineau Syndrome
| Article | Year |
|---|---|
Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].
Topics: Animals; Arousal; Azepines; Cataplexy; Dogs; Dopamine Agonists; Electroencephalography; Electromyogr | 1999 |